Conlin, A. K., Seidman, A. D., Bach, A., Lake, D., Dickler, M., D’Andrea, G., . . . Hudis, C. A. (2010). Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer.
Citação norma ChicagoConlin, Alison K., et al. Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab As First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer. 2010.
MLA citiranjeConlin, Alison K., et al. Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab As First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer. 2010.
Opozorilo: Ti citati niso vedno 100% točni.